07

Health News's Articles in Hepatitis Disease

  • Customizing Treatment with PEGASYS® May Improve Chances for Success in Hepatitis C
    Patients with chronic hepatitis C who respond quickly to PEGASYS® (peginterferon alfa-2a) and COPEGUS® (ribavirin, USP) may have an excellent chance of achieving treatment success with a shortened course of therapy, according to interim results presented at the 57th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). Three-quarters of patients with the difficult-to-treat viral genotypes 1 and 4 who had a rapid viral response (RVR) – defined as undetectable levels
  • Roche Oral Polymerase Inhibitor R1626 Shows Strong Antiviral Activity in Chronic Hepatitis C Patient
    New clinical data on the hepatitis C polymerase inhibitor R1626 – currently in development by Roche – show viral reductions greater than those described for other polymerase inhibitors, according to data presented at the 57th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). These results were achieved in chronic hepatitis C patients infected with the difficult-to-treat genotype 1 virus.
  • AVI BioPharma Reports Results on Hepatitis C Virus Clinical Trial
    AVI BioPharma, Inc. (Nasdaq:AVII) reported results today from the second phase of its multicenter study in patients with chronic active hepatitis C virus (HCV) infection. The second phase of this exploratory trial was designed to assess the safety, tolerability, pharmacokinetics (PK), and viral and clinical response to treatment with AVI’s proprietary NEUGENE® antisense compound, AVI-4065, in HCV patients.
  • Novelos Therapeutics Enrolls 1St Patient in Hepatitis C Trial with NOV-205
    Novelos Therapeutics, Inc. (OTCBB: NVLT), a biotechnology company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the first patient has been enrolled in a hepatitis C trial with NOV-205, the company’s second compound.
  • Tripep Produces Additional Positive Data for Its Hepatitis C DNA Vaccine Using Inovio's DNA Delivery
    Inovio Biomedical Corporation (AMEX:INO) announced today that its partner, Tripep AB of Sweden, has achieved additional positive pre-clinical results showing that its ChronVac-C DNA vaccine combined with Inovio's MedPulser(R) DNA delivery system produced a strong immune response against hepatitis C virus (HCV) in a large animal model.

Sign Up for a free account or learn more.
Free Content
Free content from users at Onlypunjab.com
Our Traffic Rankings
Submit Articles
Member Login
Top Authors
Most Popular Articles
Submission Guidelines
Ezine Notifications
Article RSS Feeds
New Stuff
About Us
Site Blog
Forum
Link to Us
Contact Us
Privacy Policy
Terms of Service
Arts and Entertainment
Astrology
Casino-Gambling
Humanities
Humor
Language
Movies
Music
Philosophy
Photography
Poetry
Tattoos
Automotive
Mobile-Audio-Video
Motorcycles
Trucks
Business
Advertising
Branding
Careers-Employment
Change-Management
Customer-Service
Entrepreneurialism
Ethics
Management
Marketing
Marketing-Direct
Negotiation
Networking
Outsourcing
PR
Presentation
Resumes-Cover-Letters
Sales
Sales-Management
Sales-Teleselling
Sales-Training
Small-Business
Strategic-Planning
Team-Building
Top7-or-10-Tips
Workplace and Communication
Cancer
Breast-Cancer
Colon-Rectal-Cancer
Leukemia-Lymphoma-Cancer
Lung-Mesothelioma-Asbestos
Ovarian-Cervical-Uterine-Cancer
Prostate-Cancer
Skin-Cancer
Communications
Computer
Certification-Tests
Data Recovery
Games
Hardware
Mobile-Computing
Personal Technology
Software
PHP
Web
html
Family
Babies-Toddler
Crafts-Hobbies
Elder Care
Holidays
Home Appliances
Home Audio/Video
Home Improvement
Home Security
Interior Decorating
Kids
Landscaping-Gardening
Parental Care
Pets
Pregnancy
Bankruptcy
Credit
Currency Trading
Debt Consolidation
Debt-Relief
Estate Plan Trusts
Insurance
Investments
Loans
Mortgages
Mutual Funds
Personal Finance
Real Estate
Real Estate FSBO
Structured Settlements
Taxes
Wealth Building
Food and Drink
Chocolate
Coffee
Cooking-Tips
Recipes
Wine-Spirits
Health
Acne
Aerobics Cardio
Alternative
Anti Aging
Beauty
Build Muscle
Depression
Diabetes
Exercise
Fitness Equipments
Hair Loss
Medicine
Meditation
Mens Issues
No Smoking
Nutrition
Obesity
Polution
Sidha
Supplements
Weight Loss
Womens Issues
Yoga
Home Based Business
Network-Marketing
Internet and Businesses Online
Affiliate-Revenue
Auctions
Audio-Streaming
Autoresponders
Blogging
Domain-Names
E-Books
Ecommerce
Email-Marketing
Ezine-Publishing
Forums
Internet-Marketing
List-Building
Podcasting
RSS
Security
Spam-Blocker
Video-Streaming
Web-Design
Web-Development
Web-Hosting
Kids and Teens
Legal
Identity-Theft
Living-Will
News and Society
Dating
Divorce
Economics
Love
Marriage-Wedding
Politics
Relationships
Religion
Sexuality
Reference and Education
College University
Education
Future Concepts
Home-Schooling
Science
Self Improvement
Addictions
Anger-Management
Attraction
Coaching
Creativity
Goal-Setting
Grief-Loss
Happiness
Innovation
Inspirational
Leadership
Motivation
Organizing
Positive-Attitude
Spirituality
Stress-Management
Success
Time-Management
Shopping and Product Reviews
Book-Reviews
Fashion-Style
Jewelry-Diamonds
Sport
Baseball
Cycling
Fishing
Football
Golf
Martial Arts
Running
Soccer
Swimming
Triathlon
Technology
Broad band
GPS
Mobile
Statellite
Video Conferencing
VOIP
Travel and Leisure
Aviation
Cruising-Sailing
Outdoors
Vacation-Rentals
Website Promotion
PPC-Advertising
SEO
Site-Promotion
Traffic-Building
Womens Interests
Writing and Speaking
Book-Marketing
Copywriting
Public-Speaking
Teleseminars
Writing
Writing-Articles
07

Powered by Article Dashboard